Clinical efficiency of desloratadine therapy in children with persistent form of allergic rhinitis and its effect on bronchial asthma symptoms

The research goal was to study the clinical efficiency of desloratadine therapy in children with persistent form of allergic rhinitis and to evaluate its effect on bronchial asthma symptoms. A prospective, randomized, open, parallel-group study of the effectiveness of desloratadine in children with persistent allergic rhinitis aged 2 - 16 in a four-week term was carried out. the effectiveness of therapy was evaluated by dynamics of clinical symptoms and rhinomanometry. the study showed that desloratadine was an effective medication in treatment of persistent allergic rhinitis in children of different age groups. It controlled nasal and other symptoms of allergic rhinitis and provided the reduction of stuffiness in nose and improvement of breathing through the nose. the medication significantly effected histamine-induced symptoms (itching, sneezing, rhinorrhea). In children with allergic rhinitis and bronchial asthma the positive dynamics of symptoms of asthma was observed. the effectiveness of treatment with desloratadine in children with isolated allergic rhinitis was proved to be higher than in patients with concomitant bronchial asthma